Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT03617926 · ClinicalTrials.gov registry record · NA

A Clinical Trial to Evaluate Efficacy and Safety of a Water-soluble Head Lice Product.

A NA study of Head Lice and Pediculosis Capitis, sponsored by Oystershell.

Completed
Registry status
NA
Development phase
70
Enrollment target
2
Study locations

NCT03617926 is a NA study of Head Lice and Pediculosis Capitis that has completed, run by Oystershell. The registered enrollment target is 70 participants, below the 103-participant average among 5 other Head Lice trials with a reported enrollment target (32% lower). The trial reports 2 study locations across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT03617926, a NA study of Head Lice and Pediculosis Capitis, has completed, sponsored by Oystershell.

COMPLETED
Registry status
NA
Development phase
70 participants
Enrollment target
2
Study locations

Study Summary

The present study is set-up to compare in vivo clinical performance and safety of the test product versus an in the US commercially available, pyrethrum-based product (RID® shampoo).

Interventions

  • DEVICE X92001666
  • OTHER RID shampoo

Study Locations (2)

Florida

  • South Fla. Family Health & Research Ctr.LLC - Miami
  • Lice Source Services, Inc. - Plantation

Trial Details

FieldValue
Enrollment Target 70 participants
Start Date 2018-03-07
Est. Completion 2018-06-30
Phase NA

Sponsor

Oystershell

5 total trials

What the Registry Record Tells You About NCT03617926

The ClinicalTrials.gov registry entry for NCT03617926 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 70 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 103-participant average among 5 other Head Lice trials with a reported enrollment target (32% lower). The listed sponsor is Oystershell, which has 5 total studies on file at ClinicalTrials.gov.

The record links to 2 conditions, with Head Lice appearing as the primary indexed condition, and to 2 interventions - of which X92001666 is the first listed.

NCT03617926 reports 2 study locations spanning 1 distinct geographic area - top geographies include Florida.

Frequently Asked Questions

What is clinical trial NCT03617926 about?

NCT03617926 is a clinical study titled "A Clinical Trial to Evaluate Efficacy and Safety of a Water-soluble Head Lice Product.". The present study is set-up to compare in vivo clinical performance and safety of the test product versus an in the US commercially available, pyrethrum-based product (RID® shampoo).

What is the current status of trial NCT03617926?

This trial is currently completed. It is a NA study. The enrollment target is 70 participants. The study started on 2018-03-07. Estimated completion is 2018-06-30.

What conditions does trial NCT03617926 study?

This clinical trial studies the following conditions: Head Lice, Pediculosis Capitis.

What interventions are being tested in trial NCT03617926?

The interventions under investigation include: X92001666 (DEVICE), RID shampoo (OTHER).

Who is sponsoring clinical trial NCT03617926?

This trial is sponsored by Oystershell, which has 5 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT03617926 being conducted?

This trial has 2 study locations across Florida. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Head Lice

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.